Though HCAR1 could be a good target for cancer therapeutics, the wide expression of HCAR1 in various tissues, such as brain, adipose tissue, retina, and blood vessels and the broad distribution of lactate through circulation, may limit the therapeutic options targeting HCAR1. This evidence concerns the gene HCAR1 and cancer.